Aura Biosciences, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a AURA research report →
About the company
Headquartered in Cambridge, Massachusetts, Aura Biosciences, Inc. is a biotechnology firm established in 2009 that specializes in pioneering cancer treatments. The company leverages its proprietary virus-like drug conjugate (VDC) technology platform to address tumors with significant unmet medical needs, specifically in ocular (eye) and urologic oncology.
- CEO
- Elisabet de los Pinos
- IPO
- 2021
- Employees
- 106
- HQ
- Boston, MA, US
Price Chart
- Market Cap
- $496.91M
- P/E
- -4.64
- P/S
- 0.00
- P/B
- 4.87
- EV/EBITDA
- -3.86
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -78.12%
- ROIC
- -95.48%
- Revenue
- $0 · 0.00%
- Net Income
- $-106,191,000 · -22.17%
- EPS
- $-1.76 · -0.57%
- Op Income
- $-112,791,000
- FCF YoY
- -5.10%
- 52W High
- $9.54
- 52W Low
- $4.73
- 50D MA
- $7.22
- 200D MA
- $6.28
- Beta
- 0.39
- Avg Volume
- 614.57K
Get TickerSpark's AI analysis on AURA
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jul 1, 26 | Kilroy Conor | other | 14,858 |
| Jun 16, 26 | Gibney Anthony S | sell | 12,824 |
| Jun 11, 26 | Bitetti Teresa Marie | other | 15,000 |
| Jun 11, 26 | Bitetti Teresa Marie | other | 30,000 |
| Jun 11, 26 | Srivastava Sapna | other | 15,000 |
| Jun 11, 26 | Srivastava Sapna | other | 30,000 |
| Jun 11, 26 | Johnson David Michael | other | 15,000 |
| Jun 11, 26 | Johnson David Michael | other | 30,000 |
| Jun 11, 26 | Mattessich Antony C. | other | 15,000 |
| Jun 11, 26 | Mattessich Antony C. | other | 30,000 |
Our AURA coverage
Recent articles, reports, and earnings notes.
No research on AURA yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate AURA report →Similar companies
Peers in the same neighborhood.